Biguanides mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Mechanism of Action of Biguanides
Introduction to Biguanides
Biguanides, primarily known for their antidiabetic properties, have garnered significant attention for their potential anticancer effects. Despite their widespread use, the precise mechanisms through which they exert their therapeutic effects remain a topic of ongoing research and debate.
Inhibition of Mitochondrial Complex I
One of the most widely accepted mechanisms is the inhibition of mitochondrial complex I. This inhibition leads to a decrease in ATP production, causing energy stress within the cell. The resulting energy deficit activates compensatory responses mediated by energy sensors such as AMP-activated protein kinase (AMPK) . However, it is important to note that the concentrations of biguanides required to inhibit complex I in vitro are much higher than those tolerated in clinical settings, suggesting additional mechanisms are at play.
Effects on Oxidative Phosphorylation
Biguanides also impact oxidative phosphorylation by inhibiting the primary reactions of the energy-conserving pathway. They bind to mitochondrial and synthetic membranes, altering their physical properties and affecting ion fluxes and electrical conductance. This binding modifies the mitochondrial membrane's structure, which in turn affects the electron transport chain and ATP synthesis .
Inhibition of Gluconeogenesis
Another significant mechanism is the inhibition of gluconeogenesis. Biguanides inhibit key enzymes involved in this metabolic pathway, such as pyruvate carboxylase and mitochondrial glycerophosphate dehydrogenase (mGPD), thereby reducing glucose production in the liver . This inhibition is particularly relevant in diabetic patients, where gluconeogenesis is often upregulated.
Interaction with Cellular Signaling Pathways
Biguanides also interact with various cellular signaling pathways. For instance, they have been shown to modulate the cAMP/PKA pathway, acting as glucagon antagonists and thereby reducing fasting glucose levels. Additionally, biguanides can bind to cytosolic proteins like Coronin1C, which plays a role in actin homeostasis and signal transduction, further influencing cellular metabolism and energy balance.
Antitumor Properties
In oncology, biguanides exploit the metabolic vulnerabilities of cancer cells. They can induce energy stress and activate AMPK, leading to the inhibition of mTOR signaling, which is crucial for cell growth and proliferation . Moreover, biguanides have been shown to reduce cell viability and hormone secretion in various tumor cell lines, suggesting their potential as anticancer agents.
Conclusion
The mechanism of action of biguanides is multifaceted, involving the inhibition of mitochondrial complex I, modulation of oxidative phosphorylation, inhibition of gluconeogenesis, and interaction with cellular signaling pathways. These combined effects contribute to their therapeutic efficacy in treating diabetes and potentially cancer. Understanding these mechanisms in greater detail could lead to improved therapeutic strategies and outcomes for patients.
Sources and full results
Most relevant research papers on this topic